The typical case for the fund is to invest in rounds with 3 participants. Despite the VRP Rhineland Palatinate Fund, startups are often financed by Rheinland-Pfalz Fonds, KfW, High-Tech Gru00fcnderfonds. The meaningful sponsors for the fund in investment in the same round are KfW, High-Tech Gru00fcnderfonds.
The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2010. The common things for fund are deals in the range of 5 - 10 millions dollars.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Galantos Pharma Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical.
| Fund Name | Location |
| Clean Pacific Ventures | California, San Francisco, United States |
| Gaohe Hantong Equity Investment Fund | - |
| GlobalNetFinancial | Boca Raton, Florida, United States |
| GTC Biotherapeutics | Framingham, Massachusetts, United States |
| Hanseatic Asset Management | - |
| Harwood Private Equity | England, London, United Kingdom |
| How2TV | California, Los Angeles, United States |
| NorthSpring Capital Partners | Cambridge, Canada, Ontario |
| Tohnetsupanekon | Japan, Tokyo |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Galantos Pharma | $5M | 10 May 2010 | Mainz, Rhineland-Palatinate, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Galantos Pharma | $5M | 10 May 2010 | Mainz, Rhineland-Palatinate, Germany |
